Chester County News and Community Website
NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX) announced preliminary safety and efficacy data from an investigator-initiated Phase 1/2a trial of oral rigosertib plus the immune checkpoint inhibitor nivolumab in …
Read More
CHEYNEY, PA — Navrogen Inc. and Tavotek Biotherapeutics announced today that they have entered into a strategic collaboration to identify and develop experimental monoclonal antibodies (mAbs) for the treatment of …
Read More NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced the publication of a preclinical study …
Read More
PLYMOUTH MEETING, PA — Geneos Therapeutics, a clinical-stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer, announced positive preliminary results of its ongoing first-in-human trial. …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or …
Read More